Logo-jcvtr

J Cardiovasc Thorac Res. 2016;8(1): 8-12. doi: 10.15171/jcvtr.2016.02
PMID: 27069561        PMCID: PMC4827141

Original Article

Effects of bromocriptine mesylate on homocysteine and high-sensitivity C-reactive protein levels in patients with type-2 diabetes mellitus

Mitra Niafar 1, Leili Pourafkari 2, Kavus Shahsavarinia 1, Nushin Milanchian 1, Farhad Niafar 1, Nader D. Nader 2 *

Cited by CrossRef: 1


1- Siamashvili M, Davis S. Late phase completed clinical trials investigating bromocriptine mesylate quick release as treatment of type 2 diabetes mellitus. Expert Opinion on Pharmacotherapy. 2021;22(2):241 [Crossref]